Survival analysis of metastatic colorectal cancer patients who were treated with the five major therapeutic agents over the course of disease
Articles > Article · 2013
Authors: U. Varol, Y. CIRAK, Burcu ÇAKAR, Betül KARACA, C. SEZGIN, RÜÇHAN USLU, BÜLENT KARABULUT
JOURNAL OF BUON, Journal Indexed in SCI Expanded, International, 2013, vol 18, pp 647-652
Summary
Purpose: Exposure to all active agents may be more important than specific sequence of drug administration in the treatment of patients with metastatic colorectal cancer (mCRC). The purpose of this study was to evaluate the overall survival (OS) of mCRC patients who were treated with all 5 major therapeutic agents used in this malignancy.